Member Info for gixer

Around £8.5k. Maybe not a lot but nice to see a large buy when volume has been so low.

Around £8.5k. Maybe not a lot but nice to see a large buy when volume has been so low.

1 million buy showing on Aquis.

To be honest I have no idea when this trial/study was completed. It could be recent or it could have been from a while ago and they have just decided to publish the results.
As for Blue Hat/Cap......
The last thing we were told was
"By-Health’s regulatory clearance preparations for Fruitflow were originally focussed on obtaining blue cap
health claim status for some Fruitflow based products in China, under the existing 27 permitted health function
claim structure.
By-Health is now working on an extensive regulatory submission to the SAMR for Fruitflow, seeking to establish
a new permitted health function claim for foods such as Fruitflow that can demonstrate an anti-platelet effect,
inhibiting platelet function and conferring beneficial effects for people who are at risk of platelet hyperactivity associated thrombosis - the aberrant blood clots which lead to heart attacks and strokes."

Hoping that we might get a trading update this year but who knows.

Received: 07 Mar 2022; Accepted: 25 Apr 2022.

Provisionally accepted
The final version of the article will be published here soon pending final quality checks

Four-week supplementation of water-soluble tomato extract attenuates platelet function in Chinese healthy middle-aged and older individuals: A randomized, double-blinded, crossover clinical trial.

https://www.frontiersin.org/articles/10.3389/fnut.2022.891241/full

wellsite, we all know that part of the recent agreement with By-Health was to have the ability to research Fruitflow as a Drug.
"(2) During the period of the drug research and development agreement, Provexis and the company will cooperate in drug research and development projects according to the terms of this agreement, and the company has the exclusive right to research and development of drugs in the agreement area."
https://data-eastmoney-com.translate.goog/notices/detail/300146/AN202111051527225504.html?_x_tr_sch=http&_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en-US&_x_tr_pto=wapp
so maybe they are looking at different compositions/formulations.

wellsite, I was thinking more about an independent report but something from Provexis would be good as well.
:)

"For adults 60 years or older: Do not initiate aspirin for primary prevention of CVD."

What we need now is a report to highlight what safe alternatives are available for the adults over 60.

IMO yes, but who knows.

April 26, 2022
What is the difference between Antiplatelet Aggregation Neoplexin (Water-Soluble Tomato Concentrate) and Aspirin?
https://tech-ifeng-com.translate.goog/c/8FWkiA3Z1In?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

April 26, 2022
How does Antiplatelet Aggregation Neoplexin (Water-Soluble Tomato Concentrate) Work?
https://tech-ifeng-com.translate.goog/c/8FVOR7Y7YTn?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

April 26, 2022
How does Antiplatelet Aggregation Neoplexin (Water-Soluble Tomato Concentrate) Work on Cardiovascular?
https://tech-ifeng-com.translate.goog/c/8FWnQtQZqIt?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=wapp#:~:text=%E5%AE%9E%E9%AA%8C%E7%BB%93%E6%9E%9C%E6%98%BE%E7%A4%BA%EF%BC%8C%E6%B0%B4%E6%BA%B6%E6%80%A7,%E8%A1%80%E6%A0%93%E5%BD%A2%E6%88%90%E5%92%8C%E4%BF%9D%E6%8A%A4%E8%A1%80%E5%B0%8F%E6%9D%BF%E3%80%82

another from BINH
posted yesterday.
https://www-zhihu-com.translate.goog/question/64481903/answer/2450458468?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

Unfortunately I didn't get any at that price alf but did get a few at 0.25 around that time :)

4th March 2019 0.215

BINH
By-Health institute of Nutrition and Health
https://www-zhihu-com.translate.goog/question/419045458/answer/2448883910?_x_tr_sl=zh-CN&_x_tr_tl=en&_x_tr_hl=en&_x_tr_pto=sc

Looks like all the cheap shares were hoovered up early this morning.

New name but used to be called MK-7 Artery Circulation and launched Sept 2015
https://kusoglife.com/products/dr-sinatra-mk-7-artery-circulation/
https://milled.com/healthy-directions/discover-new-mk-7-artery-circulation-aJxLzol187HLVofE

Snippet.
https://www.linkedin.com/feed/update/urn:li:activity:6918112186821185536/?updateEntityUrn=urn%3Ali%3Afs_updateV2%3A%28urn%3Ali%3Aactivity%3A6918112186821185536%2CFEED_DETAIL%2CEMPTY%2CDEFAULT%2Cfalse%29

https://www.frontiersin.org/articles/10.3389/fphar.2021.766293/full
Soluble Non-Starch Polysaccharides From Plantain (Musa x paradisiaca L.) Diminish Epithelial Impact of Clostridioides difficile
"Plantain (Musa x paradisiaca L.) non-starch polysaccharide (NSP) preparations from excipient-free plantain flour (Trobana Green Plantain flour AAB group (Horn)); Confoco International Ltd.; Ripley, United Kingdom) were prepared by Provexis plc (Reading, United Kingdom) at the Teagasc Food Research Centre (Moorepark, Ireland) as previously described"......

"NO’K is a present, and CR a past, employee of Provexis Plc. BC, HS and JR received additional funding support from the biotech partner Provexis Plc as part of the BBSRC Industrial CASE studentship (BB/I016783/1). JR is listed as inventor on patents held by Provexis Plc, in a licence agreement with the University of Liverpool, for use of complex oligosaccharides in the prevention or treatment of inflammatory bowel disease (US8945639B2), and for use of soluble fibres in antibiotic-associated diarrhoea (US20120165289A1).".....

"We are also grateful to Drs Peter Laing, David O’Brien, Patrick Druggan and Helen Martin, all former employees of Provexis plc, for additional support in research and development, access to laboratory facilities, sponsorship and intellectual discussion regarding the studies."

https://www.bbc.co.uk/news/health-61010090

RBC Plus Booklet
https://pubhtml5.com/fxcg/ygmy/basic/